Evidence map›Paper›PMID 32875241›Full record

ArticleACS omega2020

Deep Neural Networks for Multicomponent Molecular Systems.

Kyohei Hanaoka

Abstract read
In one paragraph

Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kyohei HanaokaHitachi Chemical Company, Ltd., 48 Wadai, Tsukuba City, Ibaraki Prefecture 300-4247, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep neural networks (DNNs) represent promising approaches to molecular machine learning (ML). However, their applicability remains limited to single-component materials and a general DNN model capable of handling various multicomponent molecular systems with composition data is still elusive, while current ML approaches for multicomponent molecular systems are still molecular descriptor-based. Here, a general DNN architecture extending existing molecular DNN models to multicomponent systems called MEIA is proposed. Case studies showed that the MEIA architecture could extend two exiting molecular DNN models to multicomponent systems with the same procedure, and that the obtained models that could learn both the molecular structure and composition information with equal or better accuracies compared to a well-used molecular descriptor-based model in the best model for each case study. Furthermore, the case studies also showed that, for ML tasks where the molecular structure information plays a minor role, the performance improvements by DNN models were small; while for ML tasks where the molecular structure information plays a major role, the performance improvements by DNN models were large, and DNN models showed notable predictive accuracies for an extremely sparse dataset, which cannot be modeled without the molecular structure information. The enhanced predictive ability of DNN models for sparse datasets of multicomponent systems will extend the applicability of ML in the multicomponent material design. Furthermore, the general capability of MEIA to extend DNN models to multicomponent systems will provide new opportunities to utilize the progress of actively developed single-component DNNs for the modeling of multicomponent systems.

Identifiers

PMID32875241
PMCPMC7450624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.